There is currently a race on for the development of viral pharma (re-engineering virus' to benefit humanity, specifically in this case to defeat cancer) There are several players, but GSK is one of the biggest and in the lead... The preliminary results do sound interesting!
All slow stochastic, CCI, and RSI indicators are giving buy signal. A nice green candle with a large volume yesterday could be a breakout!
The PEAD projected a Bullish outlook for $GSK after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 66.67%.
The PEAD projected a Neutral outlook for $GSK after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 77.78%.
GSK is trading around the multi year lows having bounced off of the long term support zone at 1300. I think this is a relative bargain at these levels with GSK being one of the Big Pharma Companies that is still trading way below the starting price for the year. Pfizer, Johnson & Johnson and Roche are all either positive or around net zero YTD. Novartis is...
GSK option trade. Expecting it to touch Yellow trend line. Momentum is really good.
good spot to long $GSK. set a progressive stop under yesterday's lows.
Based on historical movement, the trough could occur anywhere in the larger red box. The final targets are in the green boxes. The pending top should occur within the larger green box as has been the historical case. Half of all movement has ended in the smaller green box. In this instance, the signal indicated BUY on September 17, 2021 with a closing price of...
The PEAD projected a bullish outlook for $GSK after a Positive Under reaction following its earnings release placing the stock in drift A If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
Glaxosmithkline ($GSK) testing the golden resistance level 1431.5 standing outside of the upper daily Bollinger Band. This level previously reversed Glaxosmithkline down in December of 2020 and in January of this year. Selected Alpha ranks the reversal factor of this resistance level 25 points – making it the strongest golden tracked by the system at the moment....
The PEAD projected a Neutral outlook for $GSK after a Positive over reaction following its earnings release placing the stock in drift B If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
Bottom of the range looks a good place to buy GSK. Underperforming though and needs some impetus for share price growth.
The PEAD projected a Bearish outlook for $GSK after a Negative Under reaction following its earnings release placing the stock in drift D If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
Amature trader here. There is a strong pattern on GSK which is now in wave IV of an ending diagonal. Price should go to 1170 but buy around 1200 to show confirmation of a new uptrend. See here: This is a weekly chart but over the next two years it may go up 660pts to 1900, could be worth a look this is not investment advice :), I've lost more than I've won, but...
Bought to open GSK 01/21/22 38 C. *** THIS DOES NOT CONSTITUTE FINANCIAL ADVICE***